Bullish Moving Averages
11
Bearish Moving Averages
5
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
30.00Today’s High
32.0052W low
25.0052W High
49.50Open Price
30.00Prev. Close
28.0900Volume
12654.00Value
394678.26Fundamentals
Market Cap
32.10
Price to Earnings
-12.00
Price to Book Value
3.20
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
13.20
Net Profit TTM
-2.67
Cash From Operating Activity
1.05
Return on Equity %
-26.34
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
79.8
Week
74.2
Month
79.1
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
31.05
PIVOT
First Resistance
32.14
Second Resistance
33.09
Third Resistance
34.18
First Support
30.10
Second Support
29.01
Third Support
28.06
Relative Strength Index
53.35
Money Flow Index
38.39
MACD
0.11
MACD Signal
-0.19
Average True Range
3.38
Average Directional Index
10.25
Rate of Change (21)
7.63
Rate of Change (125)
-20.03
Commodity Channel Index
76.3
Williams %R
-34.8
BETA
1 Month
-2.41
3 Month
-0.62
1 Year
-0.46
3 Year
-0.1
PRICE CHANGE ANALYSIS
↑ 3.9%
1 Week
Low
High
27
34.5
↑ 11.04%
1 Month
Low
High
25
35.7
↓ -3.35%
3 Months
Low
High
25
36
↓ -15.13%
6 Months
Low
High
25
39.74
↑ 10.96%
1 Year
Low
High
25
49.5
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 3.89 | 3.56 | 3.47 | 2.70 | 3.48 | 4.49 | 3.78 | 3.03 | 5.48 | 4.75 | 3.51 | |
| Operating Expenses Qtr | 3.94 | 3.83 | 3.69 | 2.93 | 3.27 | 3.56 | 3.25 | 2.79 | 3.37 | 3.43 | 2.92 | |
| Operating Profit Qtr | -0.12 | -0.37 | -0.37 | -0.33 | 0.14 | 0.82 | 0.46 | 0.18 | 2.07 | 1.30 | 0.57 | |
| EBIDT Qtr Cr | -0.04 | -0.27 | -0.22 | -0.23 | 0.21 | 0.93 | 0.52 | 0.24 | 2.11 | 1.31 | 0.60 | |
| Depreciation Qtr | 0.38 | 0.38 | 0.39 | 0.39 | 0.38 | 0.39 | 0.40 | 0.42 | 0.51 | 0.36 | 0.38 | |
| Net Profit Qtr | -0.50 | -0.74 | -0.71 | -0.72 | -0.26 | 0.44 | 0.02 | -0.29 | 1.44 | 0.87 | 0.14 | |
| Basic EPS Qtr | -0.49 | -0.72 | -0.69 | -0.70 | -0.25 | 0.43 | 0.01 | -0.28 | 1.52 | 0.84 | 0.14 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 13.63 | 14.78 | 19.64 | 15.41 | 8.70 | |
| Operating Expenses Annual Cr | 14.39 | 12.86 | 13.17 | 11.69 | 10.24 | |
| Operating Profit Annual | -1.19 | 1.59 | 6.37 | 3.51 | -1.83 | |
| Operating Profit Margin Annual % | -8.71 | 10.78 | 32.46 | 22.80 | -21.00 | |
| Total Expenses Annual Cr | 16.30 | 14.87 | 15.18 | 14.03 | 12.92 | |
| EBIDT Annual Cr | -0.77 | 1.91 | 6.47 | 3.72 | -1.54 | |
| EBIDT Annual margin % | -5.62 | 12.95 | 32.94 | 24.12 | -17.69 | |
| Depreciation | 1.54 | 1.59 | 1.64 | 1.44 | 1.66 | |
| PAT Before ExtraOrdinary Items Annual Cr | -2.67 | -0.09 | 4.46 | 1.38 | -4.24 | |
| Net Profit Annual | -2.67 | -0.09 | 4.46 | 1.38 | -4.24 | |
| Basic EPS Annual | -2.60 | -0.09 | 4.33 | 1.45 | -4.56 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 10.14 | 7.82 | 7.86 | 3.38 | 3.80 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 2.50 | 3.01 | 3.56 | 1.45 | 5.41 | |
| Total Current Liabilities Annual Cr | 2.07 | 1.58 | 1.79 | 2.01 | 5.12 | |
| Total Capital Plus Liabilities Annual Cr | 14.71 | 17.34 | 18.14 | 11.78 | 14.34 | |
| Fixed Assets Annual | 6.79 | 8.01 | 9.57 | 7.75 | 8.70 | |
| Total Non Current Assets Annual | 10.35 | 11.49 | 10.99 | 7.90 | 11.05 | |
| Total Current Assets Annual | 4.36 | 5.86 | 7.14 | 3.88 | 3.29 | |
| Total Assets Annual | 14.71 | 17.34 | 18.14 | 11.78 | 14.34 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1.05 | -0.01 | 2.03 | 5.67 | -1.87 | |
| Cash from Investing Activity Annual | 0.14 | 0.16 | -0.51 | -0.09 | 0.24 | |
| Cash from Financing Annual Activity | -0.95 | -0.94 | -1.35 | -2.17 | 1.27 | |
| Net Cash Flow Annual | - | -0.79 | 0.17 | 3.41 | -0.35 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 9.85 | 7.60 | 7.63 | 3.29 | 4.09 | |
| ROE Annual % | -26.34 | -1.13 | 56.73 | 40.80 | -111.56 | |
| ROCE Annual % | -18.23 | 2.08 | 29.56 | 23.27 | -34.73 | |
| Total Debt to Total Equity Annual | 0.11 | 0.12 | 0.11 | 0.37 | 1.81 | |
| EBDIT Annual Margin % | -5.79 | 13.24 | 33.09 | 24.44 | -18.29 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ARVIND KARSANDAS BHANUSHALI | 8.6 | 75299207 | 0 | 0 |
| DEEPALI ARVIND BHANUSHALI | 8.6 | 75299208 | 0 | 0 |
| PARESH BHANJI BHANUSHALI | 0.76 | 75299209 | 0 | 0 |
| RAJ ARVIND BHANUSHALI | 0.76 | 75299210 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| RINKU VINOD BHANUSHALI | 8.1 | 75299224 |
| ADITYA AGRAWAL | 7.39 | 75299225 |
| VINOD PRADHAN BHANUSHALI | 5.01 | 75299226 |
| RAJESH PREMJI BHANUSHALI | 3.71 | 75299227 |
| MANAS MODI | 3.36 | 75299230 |
| AMIT MODI | 2.92 | 75299231 |
| DHVANI VINOD BHANUSHALI | 2.91 | 75299232 |
| PUSPAHAS AGRAWAL | 2.8 | 75299233 |
| POOJA RAJESH BHANUSHALI | 2.55 | 75299234 |
| RAM AWTAR RAMSISARIA | 2.4 | 75299235 |
| MANOJ RAMSISARIA | 1.99 | 75299236 |
| SHRADHA RAMSISARIA | 1.47 | 75299237 |
| SAAKSHI GUPTA | 1.4 | 75299238 |
| HUF | 8.49 | 75299216 |
| VINOD PRADHAN BHANUSHALI HUF | 2.91 | 75299217 |
| AMIT MODI HUF | 2.82 | 75299218 |
| GLORIOUS HOLDINGS PVT LTD | 5.59 | 75299220 |
| SOCRADAMUS CAPITAL PRIVATE LIMITED | 1.22 | 75299221 |
| JAY ARVIND BHANUSHALI | 2.03 | 75299243 |
| NIKUNJ VELJI MANGE | 1.82 | 75299244 |
| SHRADDHA JAGDISH BHANUSHALI | 1.14 | 75299245 |
| PANKAJ JASHWANT SHAH | 4.86 | 75299241 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 28, 2024 | Audited Results | - |
| Feb 13, 2024 | Quarterly Results | - |
| Feb 10, 2024 | Quarterly Results | - |
| Nov 11, 2023 | Quarterly Results | - |
| Aug 12, 2023 | Quarterly Results | - |
| May 27, 2023 | Audited Results | - |
| Feb 14, 2023 | Quarterly Results | - |
| Nov 12, 2022 | Quarterly Results | - |
| Aug 13, 2022 | Quarterly Results & A.G.M. | - |
| May 28, 2022 | Audited Results | - |
| Feb 12, 2022 | Quarterly Results | - |
| Nov 13, 2021 | Quarterly Results | - |
| Aug 14, 2021 | Quarterly Results & A.G.M. | - |
| Jun 05, 2021 | Audited Results | - |
| Feb 13, 2021 | Quarterly Results | - |
| Nov 10, 2020 | Quarterly Results | - |
| Aug 29, 2020 | A.G.M. | - |
| Jul 28, 2020 | Quarterly Results & Preferential issue | - |
| Jun 13, 2020 | Audited Results | - |
| Feb 04, 2020 | Quarterly Results | - |
| Nov 02, 2019 | Quarterly Results | - |
| Aug 21, 2019 | Preferential Issue of shares | - |
| Aug 14, 2019 | Preferential Issue of shares | Inter alia, to consider and approve issuance and allotment of equity shares by way of preferential allotment, subject to obtaining the approval of the shareholders of the Company. |
| Jul 20, 2019 | Quarterly Results | - |
| May 18, 2019 | Audited Results | - |
| Jan 21, 2019 | Others | 1)To review the performance of non-independent directors and the Board as whole. 2)To assess the quality, quantity and timelines of flow of information between the Company management and the Board. |
| Oct 27, 2018 | Quarterly Results | - |
| Aug 11, 2018 | Unaudited Financial Results | - |
| May 29, 2018 | Audited Results | - |
| Apr 21, 2018 | Others | To increase authorized capital and alter Memorandum and Article of Association of the Com. |
| Feb 05, 2018 | Quarterly Results & Others | Inter alia, to consider proposal for voluntary delisting from Calcutta Stock Exchange Limited and Metropolitan Stock Exchange of India Limited. |
| Ex-Date | Bonus Ratio | Record Date |
|---|
29 Jun 2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
Intimation of the Closure of Trading Window for the declaration of Unaudited Financial Results for the quarter ended June 30, 2024
29 Jun 2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Enclosed herewith Form C received from Mr.Jay Bhanushali, Promoter & Director Immediate Relative of the Company for the acquisition of Equity Shares from the market as on June 28, 2024.
29 Jun 2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Enclosed herewith Form C received from Mrs. Shraddha Bhanushali, Director & Promoters Immediate Relative of the Company for the acquisition of Equity Shares from the market as on June 28, 2024.
29 Jun 2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Enclosed herewith Form C received from Mr. Nikunj Velji Mange, Executive Director (08489442) of the Company for the acquisition of Equity Shares from the market as on June 28, 2024.
08 Jun 2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Reminder To Update KYC Details Pursuant To SEBI Circulars
Reminder to the Holders of the Physical Securities to furnish PAN, KYC Details and Nomination as per SEBI Circular.
30 May 2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of the Financial Results for the quarter & financial year ended March 31, 2024.
29 May 2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Enclosed herewith Annual Secretarial Compliance Report for the Financial Year Ended March 31, 2024.
28 May 2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation For The Appointment Of Secretarial Auditor And Internal Auditor Of The Company
Appointment of Secretarial Auditor & Internal Auditor of the Company for the Financial Year 2024-2025
28 May 2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome for For The Quarter And The Financial Year Ended March 31, 2024
Audited Financial Results for the quarter and Financial Year ended March 31, 2024
18 May 2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for To Consider And Approve Audited Financial Statements Of The Company As On March 31, 2024 And To Discuss Any Other Matter With The Permission Of The Chair.
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve Audited Financial Statements (Standalone) of the Company for the fourth quarter and year ended as on March 31, 2024 and to discuss any other matter with the permission of the Chair.
